Rapidly autopsied postmortem human brain and blood specimens from sporadic Alzheimer’s disease (AD), Autosomal Dominant AD, and Controls

The contract involves the procurement of rapidly autopsied postmortem human brain and blood specimens from individuals diagnosed with sporadic Alzheimer's disease, Autosomal Dominant Alzheimer's disease, as well as control subjects. This acquisition is intended to support research efforts focused on these conditions by providing high-quality biological samples collected promptly after death. The solicitation is identified by the number PCA-NIA-05858 and is issued by the National Institutes of Health within the Department of Health and Human Services. The solicitation was posted on June 4, 2026, with a response deadline set for June 14, 2026. The work will be performed in Baltimore, Maryland, and falls under NAICS code 325414, which corresponds to biological product manufacturing. The primary point of contact for this opportunity is Luz Casey, with Michael L. Falzone serving as a secondary contact. The contract type is listed as a presolicitation, indicating that the formal solicitation has not yet been issued but interested parties can prepare their responses in advance.